Foreign ministers from Japan, China and South Korea sought trilateral cooperation on common ground in areas like aging, ...
Esperion Therapeutics ESPR announced that it has come to an alignment with the FDA for initiating two phase III studies. The ...
BB-1701 has survived Eisai’s decision not to option the HER2-directed antibody-drug conjugate. | BB-1701 has survived Eisai’s ...
Ovarian cancer (OC) is the fifth most common cause of cancer-related mortality worldwide and represents the leading cause of death for gynecological malignancies. Nevertheless, over the last years, ...
As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...
Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...
Representatives from politics, business and science have signed a Memorandum of Understanding (MOU) to establish a ...
The FTSE 100 company, which has a market capitalisation of £185.9 billion, confirmed the deal in an announcement to the London Stock Exchange on Monday. AstraZeneca was advised by a Covington team led ...
A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...
What is the Purpose of Cancer Clinical Trials? 2. What is the Role of Clinical Trials in Cancer Treatment, Including Risks ...
The Fukushima Daiichi nuclear power plant's radiation levels have significantly dropped since the meltdown in Japan 14 years ...